Gene Therapy Breakthroughs
Gene therapy has moved from theoretical to transformative. The UK has approved gene therapies for sickle cell disease and haemophilia, and clinical trials continue to refine these approaches, test new delivery methods, and expand to additional conditions. Trials at centres like UCL Great Ormond Street, Oxford, and Cambridge are pushing the boundaries of what gene therapy can treat.
CRISPR and Gene Editing Trials
CRISPR-based treatments have entered clinical trials in the UK, with sickle cell disease being a flagship indication. Casgevy (exagamglogene autotemcel) became the first CRISPR-based medicine approved by the MHRA. Trials are now exploring CRISPR approaches for other genetic blood disorders, metabolic conditions, and inherited eye diseases.
Orphan Drug Development
The UK's Orphan Drug designation provides incentives for developing treatments for rare conditions. This has led to a surge in rare disease trials, with pharmaceutical companies and academic centres collaborating through networks like the National Institute for Health Research (NIHR) Rare Diseases Translational Research Collaboration.
๐ Conditions
๐ Treatments
โ๏ธ Comparisons
๐ฐ Related Articles
- Gene Therapy Clinical Trials UK 2026 Guide โ Guide to gene therapy including CRISPR and viral vector approaches
- Sickle Cell Disease Clinical Trials UK โ Gene editing and curative approaches for sickle cell
- Cystic Fibrosis Clinical Trials UK โ Triple therapy and next-generation CFTR modulators
Frequently Asked Questions
Find Your Clinical Trial
Search thousands of actively recruiting trials across the UK โ free, instant, no registration.
Search Trials Now Read the Guide